CHARLES J. FISHER, JR., MD

Corporate Board Profile

Tech Score: 0/100

AETHLON MEDICAL INC

Filing Date	Source Excerpt
2018-02-16	Charles J. Fisher, Jr. (4) Chairman and Director 71; Dr. Fisher serves as Chairman of the Board; Audit Committee members include Dr. Fisher; Director Compensation for 2017 Fiscal Year: No compensation details provided for Dr. Fisher.
2019-02-22	Dr. Fisher became a Director of Aethlon Medical, Inc. in November 2017 and was appointed as our Chairman on November 27, 2017. Dr. Fisher has been Executive Chairman of Seastar Medical, Inc., a biotechnology company, since 2013 and Chief Executive Officer of Margaux Biologics, Inc. since 2010. ... In the fiscal year ended March 31, 2018, Dr. Fisher earned $31,000 in cash compensation for his services to us as non-executive Chairman and $13,600 in Board of Directors’ fees related to his role as a Director and a member of our Audit Committee for an aggregate amount of $44,600. Dr. Fisher also received RSU’s valued at $50,000 for joining our Board of Directors per the 2012 Directors Compensation Program.

Filing Date

Source Excerpt

2018-02-16

Charles J. Fisher, Jr. (4) Chairman and Director 71; Dr. Fisher serves as Chairman of the Board; Audit Committee members include Dr. Fisher; Director Compensation for 2017 Fiscal Year: No compensation details provided for Dr. Fisher.

2019-02-22

Dr. Fisher became a Director of Aethlon Medical, Inc. in November 2017 and was appointed as our Chairman on November 27, 2017. Dr. Fisher has been Executive Chairman of Seastar Medical, Inc., a biotechnology company, since 2013 and Chief Executive Officer of Margaux Biologics, Inc. since 2010. ... In the fiscal year ended March 31, 2018, Dr. Fisher earned $31,000 in cash compensation for his services to us as non-executive Chairman and $13,600 in Board of Directors’ fees related to his role as a Director and a member of our Audit Committee for an aggregate amount of $44,600. Dr. Fisher also received RSU’s valued at $50,000 for joining our Board of Directors per the 2012 Directors Compensation Program.

Data sourced from SEC filings. Last updated: 2026-02-03